Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiumin Qu

Showing results (121-130 of 122) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 122 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 14, 2018
The cost of Alzheimer's disease in China and re-estimation of costs worldwideJianping Jia, Cuibai Wei, Shuoqi Chen, et al.
Alzheimer'S Research & Therapy|March 18, 2021
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementiaShifu Xiao, Piu Chan, Tao Wang, et al.
Pageof 13

Showing results (121-130 of 122) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 122 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 14, 2018
The cost of Alzheimer's disease in China and re-estimation of costs worldwideJianping Jia, Cuibai Wei, Shuoqi Chen, et al.
Alzheimer'S Research & Therapy|March 18, 2021
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementiaShifu Xiao, Piu Chan, Tao Wang, et al.
Pageof 13